Compras de miembros de la gerencia en los últimos 6 meses | Acciones | Trans |
---|---|---|
Compras | 0 | 0 |
Ventas | N/D | 0 |
Acciones netas compradas (vendidas) | 0 | 0 |
Acciones totales pertenecientes a miembros de la gerencia | 2.68M | N/D |
Acciones netas compradas (vendidas) en % | N/D | N/D |
Compras institucionales netas del trimestre anterior al último | Acciones |
---|---|
Acciones netas compradas (vendidas) | N/D |
Cambio en acciones institucionales propias en % | N/D |
Miembro de la gerencia | Transacción | Tipo | Valor | Fecha | Acciones |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | Purchase at price 2.21 per share. | Indirecto | 4,095,130 | 06 ene 2023 | 1,853,000 |
SEIDEL-DUGAN CYNTHIA PH.D. | Conversion of Exercise of derivative security at price 1.56 - 4.77 per share. | Directo | 111,838 | 12 ene 2022 | 39,731 |
LEONARD REID | Conversion of Exercise of derivative security at price 1.56 per share. | Directo | 21,999 | 30 dic 2021 | 14,102 |
LEONARD REID | Sale at price 13.39 - 13.97 per share. | Indirecto | 40,242 | 15 dic 2021 | 3,000 |
RA CAPITAL MANAGEMENT, L.P. | Purchase at price 12.75 - 13.37 per share. | Indirecto | 4,129,398 | 16 jun 2021 | 323,298 |
EVNIN LUKE BASIL | Purchase at price 16.00 per share. | Indirecto | 2,412,784 | 04 may 2021 | 150,799 |
EVNIN LUKE BASIL | Indirecto | 04 may 2021 | 3,671,965 | ||
HBM HEALTHCARE INVESTMENTS CAYMAN LTD | Directo | 04 may 2021 | 625,995 | ||
GADICKE ANSBERT S. | Purchase at price 16.00 per share. | Indirecto | 3,920,000 | 04 may 2021 | 245,000 |
GADICKE ANSBERT S. | Indirecto | 04 may 2021 | 5,965,775 | ||
UPMC | Directo | 04 may 2021 | 1,097,756 | ||
RA CAPITAL MANAGEMENT, L.P. | Purchase at price 16.00 per share. | Indirecto | 27,440,000 | 04 may 2021 | 1,715,000 |
RA CAPITAL MANAGEMENT, L.P. | Indirecto | 04 may 2021 | 2,253,583 | ||
FLYNN JAMES E | Purchase at price 16.00 per share. | Indirecto | 12,800,000 | 04 may 2021 | 800,000 |
FLYNN JAMES E | Indirecto | 04 may 2021 | 1,752,787 | ||
MPM BIOVENTURES 2014,L.P. | Purchase at price 16.00 per share. | Indirecto | 2,012,144 | 04 may 2021 | 125,759 |
MPM BIOVENTURES 2014,L.P. | Indirecto | 04 may 2021 | 3,062,239 | ||
LAZARUS ALON | Purchase at price 16.00 per share. | Indirecto | 6,400,000 | 04 may 2021 | 400,000 |
LAZARUS ALON | Indirecto | 04 may 2021 | 1,646,634 | ||
ASANUMA SAKAE | Purchase at price 16.00 per share. | Indirecto | 5,000,000 | 04 may 2021 | 312,500 |
ASANUMA SAKAE | Indirecto | 04 may 2021 | 1,756,409 | ||
ARKIN BIO VENTURES 2, LP. | Purchase at price 16.00 per share. | Indirecto | 6,400,000 | 04 may 2021 | 400,000 |
ARKIN BIO VENTURES 2, LP. | Indirecto | 04 may 2021 | 1,646,634 | ||
SPHERA GLOBAL HEALTHCARE MANAGEMENT LP | Purchase at price 16.00 per share. | Indirecto | 7,600,000 | 04 may 2021 | 475,000 |
SPHERA GLOBAL HEALTHCARE MANAGEMENT LP | Indirecto | 04 may 2021 | 312,997 | ||
TAIHO VENTURES, LLC | Purchase at price 16.00 per share. | Directo | 5,000,000 | 04 may 2021 | 312,500 |
TAIHO VENTURES, LLC | Directo | 04 may 2021 | 1,756,409 | ||
LONGWOOD FUND III GP, LLC | Purchase at price 16.00 per share. | Indirecto | 4,000,000 | 04 may 2021 | 250,000 |
LONGWOOD FUND III GP, LLC | Indirecto | 04 may 2021 | 1,427,082 |